NASDAQ:BLFS BioLife Solutions (BLFS) Stock Price, News & Analysis $38.61 0.00 (0.00%) As of 10/19/2026 Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About BioLife Solutions Stock (NASDAQ:BLFS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get BioLife Solutions alerts:Sign Up Key Stats Today's Range$38.61▼$38.6150-Day Range$34.82▼$39.2252-Week Range$17.86▼$39.76VolumeN/AAverage Volume1.18 million shsMarket Capitalization$1.89 billionP/E Ratio33.28Dividend YieldN/APrice Target$31.38Consensus RatingHold Company Overview BioLife Solutions, Inc. is a life sciences technology company that develops and supplies products used to preserve, store, process and transport cells and tissues. Its solutions support the development and commercialization of cell and gene therapies, as well as other biological materials that require controlled temperature and handling conditions. The company’s product portfolio includes biopreservation media such as CryoStor and HypoThermosol, cryogenic storage bags and containers, controlled-rate freezing systems, automated thawing equipment and related laboratory tools. BioLife also offers software and data-management solutions designed to help customers monitor and manage bioproduction and cold-chain workflows. BioLife Solutions serves biopharmaceutical and biotechnology companies, contract development and manufacturing organizations, academic institutions and research laboratories. Its operations and customer base extend across the United States and international markets. The company is headquartered in Bothell, Washington, and has expanded its offerings through acquisitions and the development of complementary technologies for cell and gene therapy manufacturing.AI Generated. May Contain Errors. Read More BioLife Solutions Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks38th Percentile Overall ScoreBLFS MarketRank™: 1.923076923075 of 5 starsBioLife Solutions scored higher than 38% of companies evaluated by MarketBeat, and ranked 677th out of 903 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.0 / 5Analyst RatingHold Consensus RatingBioLife Solutions has received a consensus rating of Hold. The company's average rating score is 2.09, and is based on no strong buy ratings, 1 buy rating, 10 hold ratings, and no sell ratings.Downside RiskBioLife Solutions has a consensus price target of $31.38, representing about 18.7% downside from its current price of $38.61.Amount of Analyst CoverageBioLife Solutions has been the subject of 10 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about BioLife Solutions' stock forecast and price target. Earnings and Valuation3.1 / 5Proj. Earnings Growth433.33% Earnings GrowthEarnings for BioLife Solutions are expected to grow by 433.33% in the coming year, from $0.03 to $0.16 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of BioLife Solutions is 33.28, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.75.Price to Earnings Ratio vs. SectorThe P/E ratio of BioLife Solutions is 33.28, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.57.Price to Book Value per Share RatioBioLife Solutions has a P/B Ratio of 5.00. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about BioLife Solutions' valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted8.36% of the float of BioLife Solutions has been sold short.Short Interest Ratio / Days to CoverBioLife Solutions has a short interest ratio ("days to cover") of 4.33.Change versus previous monthShort interest in BioLife Solutions has recently increased by 2.96%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldBioLife Solutions does not currently pay a dividend.Dividend GrowthBioLife Solutions does not have a long track record of dividend growth. News and Social Media1.5 / 5News Sentiment0.44 News SentimentBioLife Solutions has a news sentiment score of 0.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 2 news articles for BioLife Solutions this week, compared to 4 articles on an average week. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, BioLife Solutions insiders have not sold or bought any company stock.Percentage Held by Insiders2.20% of the stock of BioLife Solutions is held by insiders.Percentage Held by Institutions93.24% of the stock of BioLife Solutions is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about BioLife Solutions' insider trading history. Receive BLFS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioLife Solutions and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BLFS Stock News HeadlinesBioLife Solutions (NASDAQ:BLFS) and Seer (NASDAQ:SEER) Head-To-Head SurveyOctober 18 at 4:15 AM | americanbankingnews.comCan BioLife Solutions (BLFS) Justify Its Price On Future Cash Flow?October 17 at 5:02 PM | finance.yahoo.com“The crisis that’s emerging now is just the tip of the iceberg,” says Dr. Martin D. Weiss, who has made shocking and accurate predictions for 55 yearsDr. Martin D. Weiss, who predicted the Dot-Com collapse and the failures of Fannie Mae, Bear Stearns, and Lehman Brothers, is warning of a developing financial crisis. The New York Times has credited him as among the first to see the dangers ahead, and Forbes dubbed him Mr. Independence. He says this emerging situation could trigger a chain reaction across banks and markets. Watch his free video breakdown and see the five steps he outlines for investors.October 20 at 1:00 AM | Weiss Ratings (Ad)BioLife Solutions, Inc.(NasdaqCM:BLFS) dropped from S&P 1000October 9, 2026 | marketscreener.comMBioLife Solutions, Inc.(NasdaqCM:BLFS) dropped from S&P Composite 1500October 8, 2026 | marketscreener.comMRepligen Closes BioLife Solutions AcquisitionOctober 6, 2026 | finance.yahoo.comThis long-term winning stock is in a growth market and just hit new 3-year highsSeptember 24, 2026 | msn.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: BioLife Solutions (BLFS) and Corbus Pharmaceuticals (CRBP)September 11, 2026 | theglobeandmail.comSee More Headlines BLFS Stock Analysis - Frequently Asked Questions How have BLFS shares performed this year? BioLife Solutions' stock was trading at $24.18 at the beginning of 2026. Since then, BLFS shares have increased by 59.7% and is now trading at $38.61. How were BioLife Solutions' earnings last quarter? BioLife Solutions, Inc. (NASDAQ:BLFS) announced its quarterly earnings data on Thursday, August, 6th. The medical equipment provider reported $0.91 EPS for the quarter, topping the consensus estimate of $0.03 by $0.88. The medical equipment provider earned $28.47 million during the quarter, compared to analysts' expectations of $27.80 million. BioLife Solutions had a net margin of 53.29% and a trailing twelve-month return on equity of 2.70%. Who are BioLife Solutions' major shareholders? Top institutional investors of BioLife Solutions include Penbrook Management LLC (0.08%), GAMMA Investing LLC (0.02%), State of Alaska Department of Revenue (0.02%) and Abel Hall LLC (0.01%). Insiders that own company stock include Casdin Partners Master Fund, L, Aby J Mathew, Greef Roderick De, Michael Rice, Troy Wichterman, Todd Berard, Garrie Richardson, Karen A Foster, Sarah Aebersold, Geraint Phillips, Sean Werner, Joydeep Goswami and Amy Duross. View institutional ownership trends. How do I buy shares of BioLife Solutions? Shares of BLFS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of BioLife Solutions own? Based on aggregate information from My MarketBeat watchlists, some other companies that BioLife Solutions investors own include Micron Technology (MU), Alibaba Group (BABA), Block (XYZ), NVIDIA (NVDA), Advanced Micro Devices (AMD), Gilead Sciences (GILD) and Intel (INTC). Company Calendar Last Earnings8/06/2026Today10/20/2026Next Earnings (Estimated)11/05/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (5m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 BLFS's financial health is in the Green zone, according to TradeSmith. BLFS has been in this zone for over 5 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Life Sciences Tools & Services Sub-IndustryLife Sciences Tools & Services Current SymbolNASDAQ:BLFS CIK834365 Webwww.biolifesolutions.com Phone(425) 402-1400Fax425-402-1433Employees155Year Founded1987Price Target and Rating Average Price Target for BioLife Solutions$31.38 High Price Target$34.00 Low Price Target$31.00 Potential Upside/Downside-18.7%Consensus RatingHold Rating Score (0-4)2.09 Research Coverage11 Analysts Profitability EPS (Trailing Twelve Months)$1.16 Trailing P/E Ratio33.28 Forward P/E Ratio1,287.00 P/E GrowthN/ANet Income-$4.59 million Net Margins53.29% Pretax Margin6.28% Return on Equity2.70% Return on Assets2.49% Debt Debt-to-Equity RatioN/A Current Ratio9.69 Quick Ratio7.14 Sales & Book Value Annual Sales$106.69 million Price / Sales17.71 Cash Flow$0.23 per share Price / Cash Flow168.62 Book Value$7.72 per share Price / Book5.00Miscellaneous Outstanding Shares48,923,000Free Float47,847,000Market Cap$1.89 billion OptionableOptionable Beta1.82 Social Links 7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (NASDAQ:BLFS) was last updated on 10/19/2026 by MarketBeat.com Staff. From Our PartnersTrump’s Plan To Cheat HistoryChina has slashed its U.S. Treasury holdings by more than 45% from their peak, while building gold vaults and ...Porter & Company | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredBuy These Five AI Plays Before October 20Jeff Brown, founder and CEO of Brownstone Research, says a new market cycle he calls the million dollar cycle ...Brownstone Research | SponsoredLast call for your free 0DTE reportThe 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, p...Profits Run | SponsoredINSANE DRONE FOOTAGENew drone footage shows a mysterious factory rising at one of Elon Musk's most secure facilities, cleared and ...Paradigm Press | SponsoredThe Iran War Isn’t Chaos. It’s Strategy.Two thousand missiles struck Iran. Three days later, Dylan Jovine sat in two private meetings with U.S. Congre...Behind the Markets | SponsoredYour book is insideBlane Markham and the Markham Trading Team are giving readers a limited window to download their options strat...TradeWins | SponsoredPalantir and Wall Street are in on it…Palantir just signed a major AI deal with a company most investors have never heard of. Wall Street has pou...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioLife Solutions, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioLife Solutions With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
